{"id": "1367302697355993089", "creation": 1614825340.0, "user_id": "785263274992529408", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 45, "reply_count": 1, "like_count": 79, "quote_count": 1}}, "quoted": "1367294839390355456", "text": "First #LatinAmerican #COVID19 #vaccine enters Phase 3 clinical trial tomorrow in 44,000 Havana residents: #Cuban vaccine #Soberana02 . Congrats! More coming from MEDICC Review. @ReviewMedicc https://t.co/OlNVvA0fk1", "first_save": 1634559108.199414, "hashtags": ["#LATINAMERICAN", "#COVID19", "#VACCINE", "#CUBAN", "#SOBERANA02"]}